Okey Stephanie — SEC insider filings
SEC reporting owner CIK 1742616. 30 insider filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2020-12-10 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 9 filings — 58,533 shares, $3,137,448 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: sale of 14,000 shares @ $70.00 ($980,000) in PTC THERAPEUTICS, INC., filed 2026-03-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. (PTCT) | Director | 13 | — | 7 legs · 31,133 sh · $1,960,645 | 17 |
| Crinetics Pharmaceuticals, Inc. (CRNX) | Director | 10 | — | 4 legs · 27,400 sh · $1,176,803 | 21 |
| ALBIREO PHARMA, INC. (ALBO) | Director | 3 | — | — | 8 |
| Catalent, Inc. (CTLT) | Director | 4 | — | — | 4 |
Insider filings — Okey Stephanie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 6,400 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 25,000 (derivative) @ $60.85 · Disposition to issuer (D): 12,500 (derivative) @ $61.77 · Disposition to issuer (D): 17,500 (derivative) @ $64.77 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · +3 more | EDGAR |
| 2026-06-22 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 6,292 @ $35.62 · Sale (S): 608 @ $36.22 | EDGAR |
| 2026-03-12 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 1,167 @ $33.63 · Sale (S): 1,167 @ $70 · Option exercise (M): 14,000 @ $33.63 · Sale (S): 14,000 @ $70 · Option exercise (M): 1,167 (derivative) @ $0 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 6,333 @ $63.38 | EDGAR |
| 2026-03-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $39.67 | EDGAR |
| 2026-01-06 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 3,475 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Gift (G): 867 @ $0 | EDGAR |
| 2025-06-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 5,000 @ $54 | EDGAR |
| 2025-01-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Catalent, Inc. (CTLT) | Disposition to issuer (D): 12,635 | EDGAR |
| 2024-11-01 | 4 | Catalent, Inc. (CTLT) | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-06-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 17,500 @ $18.29 · Sale (S): 17,500 @ $46.38 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Catalent, Inc. (CTLT) | Grant/award (A): 6,993 @ $0 | EDGAR |
| 2023-08-30 | 4 | Catalent, Inc. (CTLT) | Grant/award (A): 979 @ $0 | EDGAR |
| 2023-06-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 6,000 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | ALBIREO PHARMA, INC. (ALBO) | Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 11,000 (derivative) | EDGAR |
| 2023-01-09 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-08-11 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 2,296 @ $51.62 | EDGAR |
| 2022-06-28 | 4 | ALBIREO PHARMA, INC. (ALBO) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-01-11 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 3,200 @ $0 · Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2021-08-17 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 1,650 @ $40.06 | EDGAR |
| 2021-06-28 | 4 | ALBIREO PHARMA, INC. (ALBO) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2021-06-23 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 1,650 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2020-12-10 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 687 @ $62.52 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742616 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs